Post by Alex Devereson

What excites me most about AI in life sciences isn't the technology itself, but it's what it could mean for patients. I joined my colleagues Delphine Nain Zurkiya and Lieven Van der Veken to discuss where AI is already creating value, why scaling remains challenging, and how agentic AI could reshape drug discovery and development in the years ahead. Sharp-eyed viewers may notice a few children's toys in the background. An occupational hazard of recording from home, but also a useful reminder of why this work matters. Would love to hear how others are thinking about the opportunities and challenges ahead. Explore our conversation here ➡️https://lnkd.in/eUQaCBXT #AI #LifeSciences #DrugDiscovery #Pharma